To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes. — HR-8630 (R-OH) · Congress.wiki
To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.
house
senate
president
Introduced April 30, 2026 by Michael A. Rulli · Last progress April 30, 2026
